SureGene uses proprietary LocusLockTM technology to locate and evaluate in detail chromosomal regions that make relatively large contributions to psychological variation in the human population. These chromosomal segments contain genes that affect susceptibility to mental illnesses such as schizophrenia, bipolar disorder, and obsessive-compulsive disorder. SureGene, LLC engages in the research and development of personalized medicine for mental health developing genetic discoveries into products, such as molecular diagnostic tests that are used to improve the care of people with mental illness
